Biotech company PharmAust has put the call out for dogs to participate in a trial of its canine lymphoma drug treatment trial. As reported on the Small Caps website, PharmAust is testing the effects of their anti-cancer drug monepantel, and for the trial, they require dogs with any stage of lymphoma but who are feeling generally well. To be eligible for the new clinical trial program, dogs must also: have had no previous treatment in the last eight weeks, including corticosteroids; have no other significant concurrent medical problems; have good quality of life; and should not weigh more than 11kg. 

The program will run in New South Wales, Queensland and Western Australia with consultations and treatments occurring at five sites: Animal Referral Hospital in Homebush (Sydney), Western Australian Veterinary Emergency and Speciality in Success (Perth), Perth Veterinary Specialists in Osborne Park (Perth), Animal Referral Hospital in Sinnamon Park (Brisbane) and Veterinary Specialist Services in Underwood (Brisbane). Read more